New Drug Development for Known and Emerging Viruses: Methods & Principles in Medicinal Chemistry
Autor H Rübsamen–Schaefen Limba Engleză Hardback – 28 dec 2021
Din seria Methods & Principles in Medicinal Chemistry
- 14% Preț: 2680.91 lei
- 5% Preț: 1041.69 lei
- 14% Preț: 857.59 lei
- 14% Preț: 1009.24 lei
- 5% Preț: 933.78 lei
- 5% Preț: 914.13 lei
- 23% Preț: 791.75 lei
- 23% Preț: 800.11 lei
- 14% Preț: 704.74 lei
- 14% Preț: 877.67 lei
- 26% Preț: 1276.82 lei
- 31% Preț: 878.10 lei
- 34% Preț: 740.70 lei
- 32% Preț: 1477.68 lei
- 31% Preț: 890.72 lei
Preț: 1113.90 lei
Preț vechi: 1172.52 lei
-5% Nou
Puncte Express: 1671
Preț estimativ în valută:
213.18€ • 221.44$ • 177.08£
213.18€ • 221.44$ • 177.08£
Carte disponibilă
Livrare economică 13-27 ianuarie 25
Livrare express 27 decembrie 24 - 02 ianuarie 25 pentru 59.89 lei
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783527343379
ISBN-10: 3527343377
Pagini: 528
Dimensiuni: 177 x 252 x 30 mm
Greutate: 1.08 kg
Editura: Wiley Vch
Seria Methods & Principles in Medicinal Chemistry
Locul publicării:Weinheim, Germany
ISBN-10: 3527343377
Pagini: 528
Dimensiuni: 177 x 252 x 30 mm
Greutate: 1.08 kg
Editura: Wiley Vch
Seria Methods & Principles in Medicinal Chemistry
Locul publicării:Weinheim, Germany
Cuprins
HIV - Disease overview, targets for therapy and open issues
Curing Hepatitis C with Direct-Acting Antiviral Therapy
Antiviral Drugs against Influenza Virus
Respiratory Syncytial Virus Immunoreactivity, Vaccine development, and Therapeutics
Herpes simplex viruses
Antiviral strategies against the Human Cytomegalo Virus: Inhibitors of Viral Terminase
Antiviral targeting of the complex Epstein Barr virus life cycle
Kaposi's Sarcoma-associated Herpesvirus - antiviral treatment
Hepatitis B virus: HBV capsid assembly modulators (CAMs)
Hepatitis E virus - Current development in antiviral strategies
Antiviral Therapy of Adenovirus Infections
New Developments in Antiviral Drugs against ssDNA-Viruses: Human Parvovirus Infection
Antiviral targets and strategies to treat and prevent human norovirus infections
Antiviral strategies against (non-polio) picornaviruses
Novel antiviral strategies against emerging arbovirus infections
Current Therapies for Biosafety Level 4 Pathogens
Antiviral Strategies Against Coronaviruses